Profilin 1 controls a microglial cytoskeleton checkpoint to prevent senescence and premature synaptic decline.

["Camila Cabral Portugal", "Tiago Oliveira Almeida", "Joana Tedim-Moreira", "C\u00e1tia Silva", "Teresa Canedo", "Jo\u00e3o Galv\u00e3o", "Ana Magalh\u00e3es", "Teresa Summavielle", "Xianshu Bai", "Frank Kirchhoff", "Boris Rubinstein", "Irina Moreira", "J\u00e9ssica Costa", "Joana Guedes", "In\u00eas Mendes Pinto", "Jo\u00e3o Pe\u00e7a", "Renato Socodato", "Jo\u00e3o Bettencourt Relvas"]
Journal of neuroinflammation 2025
Open on PubMed

UNLABELLED: Profilin 1 (Pfn1) expression decreases significantly in aged human microglia, suggesting that loss of cytoskeletal integrity may trigger microglial senescence and increased synaptic vulnerability. To test this hypothesis, we used an inducible, microglia-specific Pfn1 knockout in adult mice, a strategy designed to isolate the direct effects of acute Pfn1 loss at the cellular and circuit levels, avoiding confounding factors from development or chronic aging. Using a multi-omics approach combined with intravital two-photon imaging, we found that Pfn1 ablation disrupts actin–microtubule coupling, leading to a collapse of microglial morphodynamics and a complete failure to respond to focal brain injury. This cytoskeletal disruption triggers a cell-autonomous, senescence-associated secretory phenotype (SASP), driven by the ERK/NF-κB signaling axis. SASP factors secreted by Pfn1-deficient microglia reprogram the synaptic environment, resulting in significant deficits in mitochondrial energy production and a selective reduction in the frequency of GABAergic inhibitory postsynaptic currents in the prefrontal cortex. These circuit-level disturbances lead to behaviors characterized by altered anxiety and risk assessment. Our findings identify Pfn1 as a critical checkpoint against microglial senescence and show that its loss is sufficient to drive circuit-specific synaptic decline, highlighting the Pfn1-cytoskeleton axis as a potential therapeutic target to enhance brain resilience. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-025-03588-z.

9 Figures Extracted
Fig. 1
Fig. 1 PMC
Loss of Pfn1 in microglia impairs cytoskeletal dynamics and surveillance capacity. A A schematic of the conditional knockout (cKO) model for deletin...
Fig. 2
Fig. 2 PMC
RNA sequencing reveals transcriptomic alterations in Pfn1-deficient microglia, mimicking aged phenotypes. A A volcano plot from RNA sequencing of so...
Fig. 3
Fig. 3 PMC
Loss of Pfn1 induces a senescence-like transcriptional phenotype in microglia. A Contingency analysis comparing the transcriptomic profile of Pfn1 c...
Fig. 4
Fig. 4 PMC
Pfn1 deficiency in microglia reprograms the brain transcriptome. A A diagram of the experimental workflow for bulk RNA-seq performed on cortical tis...
Fig. 5
Fig. 5 PMC
Deep proteomic and phosphoproteomic profiling reveals synaptic aging-like phenotypes in Pfn1 cKO brains. A A diagram of the experimental workflow fo...
Fig. 6
Fig. 6 PMC
Metabolic profiling reveals mitochondrial dysfunction in synaptosomes from Pfn1 cKO brains. A A diagram of the experimental workflow using the Seaho...
Fig. 7
Fig. 7 PMC
Loss of Pfn1 disrupts inhibitory synaptic transmission in the prefrontal cortex. A A histogram and chart showing the phosphorylation status of prote...
Fig. 8
Fig. 8 PMC
Behavioral characterization of Pfn1 cKO mice. A and B Morris water maze (MWM) test ( n  = 6–9 mice/genotype), displaying escape latencies during t...
Fig. 9
Fig. 9 PMC
Microglial Profilin-1 loss collapses the cytoskeleton, elicits a SASP, and depresses inhibitory synapse activity. The left-to-right schematic shows: s...